Literature DB >> 15689450

Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer's disease.

D Cheng1, R Huang, I S Lanham, H M Cathcart, M Howard, E H Corder, S E Poduslo.   

Abstract

BACKGROUND: Multiple genes have been provisionally associated with Alzheimer's disease, including the coding polymorphisms in exons 8 and 13 in the low density lipoprotein receptor gene (LDLR), situated on chromosome 19p13.2.
METHODS: The sample groups consisted of 180 AD patients and 141 control spouses. We carried out genotyping of LDLR8 and LDLR13.
RESULTS: The LDLR8 GG genotype was common, found in 84% of the unaffected control subjects and 91% of the AD patients in our study. There was a ninefold elevation in risk associated with GG:CC versus A- and T- among APOE4+ subjects when compared with APOE4- subjects (odds ratio 9.3; 95% confidence interval 1.8 to 48.2). With the additional information on LDLR polymorphism, we defined an overall 12 fold elevation in risk for APOE4 in combination with LDLR GG:CC (11.9; 2.8 to 50.0; Fisher's exact test, p = 0.0002; standard power 0.999), compared with other subjects lacking all three of these polymorphisms.
CONCLUSION: These results imply a functional interaction between ApoE and LDL receptor proteins that determines risk for Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15689450      PMCID: PMC1735987          DOI: 10.1136/jmg.2004.024968

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  20 in total

1.  Molecular characterisation of a low-frequency mutation in exon 8 of the human low-density lipoprotein receptor gene.

Authors:  M J Kotze; E Langenhoven; L Warnich; M P Marx; A E Retief
Journal:  S Afr Med J       Date:  1989-10-21

2.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

Review 3.  Functions of lipoprotein receptors in neurons.

Authors:  Uwe Beffert; Peggy C Stolt; Joachim Herz
Journal:  J Lipid Res       Date:  2003-12-01       Impact factor: 5.922

4.  Role of common genetic polymorphisms in the LDL receptor gene in affecting plasma cholesterol levels in the general population.

Authors:  Y I Ahn; M I Kamboh; C E Aston; R E Ferrell; R F Hamman
Journal:  Arterioscler Thromb       Date:  1994-05

5.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

6.  Harmful effects of increased LDLR expression in mice with human APOE*4 but not APOE*3.

Authors:  Sudi I Malloy; Michael K Altenburg; Christopher Knouff; Lorraine Lanningham-Foster; John S Parks; Nobuyo Maeda
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-09-11       Impact factor: 8.311

7.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.

Authors:  E H Corder; A M Saunders; N J Risch; W J Strittmatter; D E Schmechel; P C Gaskell; J B Rimmler; P A Locke; P M Conneally; K E Schmader
Journal:  Nat Genet       Date:  1994-06       Impact factor: 38.330

Review 8.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.

Authors:  R W Mahley
Journal:  Science       Date:  1988-04-29       Impact factor: 47.728

Review 9.  Molecular genetics of the LDL receptor gene in familial hypercholesterolemia.

Authors:  H H Hobbs; M S Brown; J L Goldstein
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

10.  Haplotypes and SNPs in 13 lipid-relevant genes explain most of the genetic variance in high-density lipoprotein and low-density lipoprotein cholesterol.

Authors:  Hans Knoblauch; Anja Bauerfeind; Mohammad Reza Toliat; Christian Becker; Tatjana Luganskaja; Ulf Peter Günther; Klaus Rohde; Herbert Schuster; Christine Junghans; Friedrich C Luft; Peter Nürnberg; Jens Georg Reich
Journal:  Hum Mol Genet       Date:  2004-03-25       Impact factor: 6.150

View more
  12 in total

Review 1.  Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.

Authors:  Christiane Reitz
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Genetic interaction between two apolipoprotein E receptors increases Alzheimer's disease risk.

Authors:  Eloy Rodríguez; Ignacio Mateo; Javier Llorca; Coro Sánchez-Quintana; Jon Infante; José Berciano; Onofre Combarros
Journal:  J Neurol       Date:  2005-11-29       Impact factor: 4.849

3.  Sex-dependent association of a common low-density lipoprotein receptor polymorphism with RNA splicing efficiency in the brain and Alzheimer's disease.

Authors:  Fanggeng Zou; Rangaraj K Gopalraj; Johann Lok; Haiyan Zhu; I-Fang Ling; James F Simpson; H Michael Tucker; Jeremiah F Kelly; Samuel G Younkin; Dennis W Dickson; Ronald C Petersen; Neill R Graff-Radford; David A Bennett; Julia E Crook; Steven G Younkin; Steven Estus
Journal:  Hum Mol Genet       Date:  2007-12-08       Impact factor: 6.150

4.  Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner.

Authors:  Lance A Johnson; Reid H J Olsen; Louise S Merkens; Andrea DeBarber; Robert D Steiner; Patrick M Sullivan; Nobuyo Maeda; Jacob Raber
Journal:  Neurobiol Dis       Date:  2014-01-09       Impact factor: 5.996

5.  Overexpression of low-density lipoprotein receptor in the brain markedly inhibits amyloid deposition and increases extracellular A beta clearance.

Authors:  Jungsu Kim; Joseph M Castellano; Hong Jiang; Jacob M Basak; Maia Parsadanian; Vi Pham; Stephanie M Mason; Steven M Paul; David M Holtzman
Journal:  Neuron       Date:  2009-12-10       Impact factor: 17.173

6.  Cluster analysis of risk factor genetic polymorphisms in Alzheimer's disease.

Authors:  C N Randall; D Strasburger; J Prozonic; S N Morris; A D Winkie; G R Parker; D Cheng; E M Fennell; I Lanham; N Vakil; J Huang; H Cathcart; R Huang; S E Poduslo
Journal:  Neurochem Res       Date:  2008-02-29       Impact factor: 3.996

Review 7.  Changing perspectives regarding late-life dementia.

Authors:  Majid Fotuhi; Vladimir Hachinski; Peter J Whitehouse
Journal:  Nat Rev Neurol       Date:  2009-11-17       Impact factor: 42.937

8.  Function and comorbidities of apolipoprotein e in Alzheimer's disease.

Authors:  Valérie Leduc; Dorothée Domenger; Louis De Beaumont; Daphnée Lalonde; Stéphanie Bélanger-Jasmin; Judes Poirier
Journal:  Int J Alzheimers Dis       Date:  2011-04-05

9.  Genetics of late-onset Alzheimer's disease: update from the alzgene database and analysis of shared pathways.

Authors:  Paolo Olgiati; Antonis M Politis; George N Papadimitriou; Diana De Ronchi; Alessandro Serretti
Journal:  Int J Alzheimers Dis       Date:  2011-12-10

10.  LDLR expression and localization are altered in mouse and human cell culture models of Alzheimer's disease.

Authors:  Jose F Abisambra; Tina Fiorelli; Jaya Padmanabhan; Peter Neame; Inge Wefes; Huntington Potter
Journal:  PLoS One       Date:  2010-01-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.